A first-of-its-kind study identifies mechanisms that explain how a drug commonly used to treat HIV and hepatitis causes kidney disease and kidney injury. The study is published ahead of print in Function.
Jan 17, 2023
0
19
Imagine riding a bike. Now imagine riding a bike with an enormous beach ball stuck on your handlebars. That "modification" might change your experience quite a bit. In our cells, molecules called phosphate groups are constantly ...
Apr 29, 2024
0
43
A new tool using cutting-edge technology is able to distinguish different types of blood clots based on what caused them, according to a study published in eLife.
May 12, 2020
0
92
An immunological test known as a "tetramer assay" can detect and quantify the T cells in a blood sample that are able to recognize a specific antigen, such as a viral protein. Making the molecular probes needed for this type ...
Apr 20, 2020
1
94
Intestinal epithelial tight junctions (TJs) act as a functional and structural barrier against harmful antigens that promote intestinal inflammation in inflammatory bowel disease (IBD) and other inflammatory conditions of ...
Apr 20, 2021
0
5
Researchers at the George Washington University (GW) Cancer Center found that the enzyme USP15 could potentially lead to new treatments for breast and pancreatic cancer. Their findings were published in Nature Communications.
Mar 15, 2019
0
89
To make it possible for cancer immunotherapy to help more people, think small.
Jan 10, 2019
0
26
A drug targeting a protein complex containing two different types of opioid receptors may be an effective alternative to morphine and other opioid pain medications, without any of the side effects or risk of dependence, according ...
Jul 15, 2013
2
0
It takes 10 to 15 years and around US$1 billion to develop one successful drug. Despite these significant investments in time and money, 90% of drug candidates in clinical trials fail. Whether because they don't adequately ...
Feb 24, 2022
0
15
Bowel cancer patients could in the future benefit from a new 3D bioprinting technology which would use their own cells to replicate the complex cellular environment of solid tumors in 3D models. The University of Bristol-led ...
Nov 2, 2022
0
32
